Fig. 2.
Changes in SPP.
(A) SPP in instep, (B) SPP in sole.
■ indicate group A (beraprost, n=35) and
■ indicate group B (cilostazol or sarpogrelate, n=33).15)
*p<0.05, #p<0.01 vs pretreatment values. NS, not significant
Changes in SPP.
(A) SPP in instep, (B) SPP in sole.
■ indicate group A (beraprost, n=35) and
■ indicate group B (cilostazol or sarpogrelate, n=33).15)
*p<0.05, #p<0.01 vs pretreatment values. NS, not significant